Stocksigma LogoStocksigma Logo

USFDA Issues Form 483 with Three Observations for Dr. Reddy’s Visakhapatnam Facility

The USFDA completed a Pre-Approval Inspection at Dr. Reddy’s Laboratories’ FTO-9 manufacturing facility in Visakhapatnam, Andhra Pradesh, conducted between

USFDA Issues Form 483 with Three Observations for Dr. Reddy’s Visakhapatnam Facility

Dr Reddys Laboratories Ltd · Others (Uncategorized) · 15 Oct 2026, 1:50 am

USFDA Issues Form 483 with Three Observations for Dr. Reddy’s Visakhapatnam Facility The USFDA completed a Pre-Approval Inspection at Dr. Reddy’s Laboratories’ FTO-9 manufacturing facility in Visakhapatnam, Andhra Pradesh, conducted between 8th Oct'26 and 9th Oct'26. Following the audit, the regulator issued a Form 483 containing three observations. Dr. Reddy’s confirmed that it will address all observations within the stipulated timeline.

Original exchange filing (PDF)

More announcements from Dr Reddys Laboratories Ltd

All Dr Reddys Laboratories Ltd announcements